LEVETIRACETAM Extended-release
NDC 81665-100, LEVETIRACETAM, tablet, extended release, from Omnivium Pharmaceuticals LLC.
- Product NDC
- 81665-100
- Status
- Listed
- Labeler
- Omnivium Pharmaceuticals LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212688
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81665-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVETIRACETAM750 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81665-100-12 | 81665010012 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (81665-100-12) |
| 81665-100-60 | 81665010060 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (81665-100-60) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1a31134d-6b63-4d14-8445-0ed132e6c88d
Use it
Look up 81665-100 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81665-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81665-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.